Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Vascular Research|January 25, 2005
Atrial natriuretic peptide preserves endothelial function during intimal hyperplasiaMelissa N Barber, Tracey A Gaspari, Evette M Kairuz, et al.
British Journal of Pharmacology|March 4, 2021
Simultaneous targeting of oxidative stress and fibrosis reverses cardiomyopathy-induced ventricular remodelling and dysfunctionChao Wang, Tracey A Gaspari, Dorota Ferens, et al.
Journal of Vascular Research|October 25, 2007
A novel histone deacetylase inhibitor reduces abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient miceAntony Vinh, Tracey A Gaspari, Hong Bin Liu, et al.
European Journal of Nutrition|February 28, 2023
Long-term dietary nitrate supplementation slows the progression of established atherosclerosis in ApoE-/- mice fed a high fat dietYang Liu, Kevin D Croft, Trevor A Mori, et al.
International Journal of Cardiology|October 29, 2013
Direct AT₂ receptor stimulation is athero-protective and stabilizes plaque in apolipoprotein E-deficient miceSonja Tesanovic Kljajic, Robert E Widdop, Antony Vinh, et al.
Life Sciences|May 23, 2026
Serelaxin has greater anti-fibrotic potential than perindopril but maintains its anti-fibrotic efficacy in the presence of perindopril in normotensive mouse models of heart diseaseZiqiao Wang, Gang She, Chao Wang, et al.
Clinical and Experimental Pharmacology & Physiology|January 20, 2010
Effect of tocopheryl phosphate on key biomarkers of inflammation: Implication in the reduction of atherosclerosis progression in a hypercholesterolaemic rabbit modelRoksan Libinaki, Sonja Tesanovic, Aileen Heal, et al.
ACS Pharmacology & Translational Science|April 8, 2020
Serelaxin and the AT2 Receptor Agonist CGP42112 Evoked a Similar, Nonadditive, Cardiac Antifibrotic Effect in High Salt-Fed Mice That Were Refractory to Candesartan CilexetilYan Wang, Lei Han, Matthew Shen, et al.
Frontiers in Pharmacology|September 16, 2017
Anti-fibrotic Potential of AT2 Receptor AgonistsYan Wang, Mark Del Borgo, Huey W Lee, et al.
Hypertension (Dallas, Tex. : 1979)|May 10, 2021
In Aged Females, the Enhanced Pressor Response to Angiotensin II Is Attenuated By Estrogen Replacement via an Angiotensin Type 2 Receptor-Mediated MechanismGiannie Barsha, Katrina M Mirabito Colafella, Sarah L Walton, et al.
Pageof 3